material transfer agreement


Also found in: Acronyms, Wikipedia.

material transfer agreement

A document that defines the conditions under which research or other materials can be transferred and used among research laboratories.
References in periodicals archive ?
Specific issues with material transfer agreements. In: Krattiger A, Mahoney RT, Nelsen L, et al., eds.
The structure of the draft SMTA laid out in 2005 departed from a classic material transfer agreement between private parties only in its Preamble.
Material Transfer Agreement of Human Biological Materials.
University of the Witwatersrand's Material Transfer Agreement template
These are available under an ARS Material Transfer Agreement to any party interested in developing them into a commercial product.
Caladrius Biosciences, a clinical-stage biopharmaceutical company that develops cell based therapeutics in the United States, has signed a material transfer agreement with the University of Southern California and the California Institute of Technology.
Premacure is developing IPLEX(TM) as a potential treatment for Retinopathy of Prematurity ("ROP") via a Material Transfer Agreement with Insmed.
Tokyo, Japan, Dec 18, 2006 - (JCN) - Takara Bio has entered into a license and material transfer agreement with the Peter MacCallum Cancer Centre in Melbourne, Australia to supply Takara Bio's RetroNectin for use in a phase I clinical trial of multiple myeloma (MM), which is being conducted by the group of principal investigator Professor Miles Prince.
Cryptome has up to 12 months to exercise the option, but is intending to begin work on the molecule under an MTA (material transfer agreement) in the immediate future.
As part of this Material Transfer Agreement which protects the rights of all the parties involved, including the countries of origin of the source plants, and which is expected to net positive results within a year, Unigen will obtain 36 anti-solid tumor plant extracts from NCI's Natural Products Repository and will utilize its PhytoLogix technology platform to carry out high-throughput purification (HTP) and identification.
(Cambridge, MA; 617-679-7480), and Harvard Medical School (Cambridge, MA) have established an umbrella material transfer agreement that will streamline collaboration, allowing scientists at the two institutions to share novel genes and other biological materials more easily.
M2 EQUITYBITES-January 22, 2015-Critical Outcome Technologies implements material transfer agreement with Dr.